The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration

C. Cencioni, S. Atlante, M. Savoia, F. Martelli, A. Farsetti, M.C. Capogrossi, A.M. Zeiher, C. Gaetano, F. Spallotta

Research output: Contribution to journalArticle

Abstract

Organ-specific mesenchymal cells naturally reside in the stroma, where they are exposed to some environmental variables affecting their biology and functions. Risk factors such as diabetes or aging influence their adaptive response. In these cases, permanent epigenetic modifications may be introduced in the cells with important consequences on their local homeostatic activity and therapeutic potential. Numerous results suggest that mesenchymal cells, virtually present in every organ, may contribute to tissue regeneration mostly by paracrine mechanisms. Intriguingly, the heart is emerging as a source of different cells, including pericytes, cardiac progenitors, and cardiac fibroblasts. According to phenotypic, functional, and molecular criteria, these should be classified as mesenchymal cells. Not surprisingly, in recent years, the attention on these cells as therapeutic tools has grown exponentially, although only very preliminary data have been obtained in clinical trials to date. In this review, we summarized the state of the art about the phenotypic features, functions, regenerative properties, and clinical applicability of mesenchymal cells, with a particular focus on those of cardiac origin. © 2016 Elsevier Inc.
Original languageEnglish
Pages (from-to)43-55
Number of pages13
JournalPharmacology and Therapeutics
Volume171
DOIs
Publication statusPublished - 2017

Keywords

  • Cardiac fibroblast
  • Cardiovascular diseases
  • Epigenetics
  • Mesenchymal stem cells
  • Metabolism
  • Regenerative medicine
  • DNA
  • enzyme
  • untranslated RNA
  • biogenesis
  • biological functions
  • cardiac mesenchymal stem cell
  • cardiac muscle cell
  • cell function
  • cell metabolism
  • cellular distribution
  • DNA methylation
  • epigenetics
  • exosome
  • genetics
  • heart muscle metabolism
  • heart regeneration
  • histone modification
  • human
  • in vivo study
  • mesenchymal stem cell
  • mesenchymal stem cell transplantation
  • mitochondrion
  • nonhuman
  • phase 1 clinical trial (topic)
  • phase 2 clinical trial (topic)
  • phenotype
  • priority journal
  • randomized controlled trial (topic)
  • regenerative ability
  • Review
  • secretory pathway
  • sensor
  • tissue regeneration
  • animal
  • cardiac muscle
  • cytology
  • fibroblast
  • genetic epigenesis
  • heart
  • mesenchymal stroma cell
  • pericyte
  • physiology
  • regeneration
  • risk factor
  • Animals
  • Epigenesis, Genetic
  • Fibroblasts
  • Heart
  • Humans
  • Mesenchymal Stromal Cells
  • Myocardium
  • Pericytes
  • Phenotype
  • Regeneration
  • Risk Factors

Fingerprint Dive into the research topics of 'The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration'. Together they form a unique fingerprint.

  • Cite this

    Cencioni, C., Atlante, S., Savoia, M., Martelli, F., Farsetti, A., Capogrossi, M. C., Zeiher, A. M., Gaetano, C., & Spallotta, F. (2017). The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration. Pharmacology and Therapeutics, 171, 43-55. https://doi.org/10.1016/j.pharmthera.2016.10.005